Early Day Motion·EDM 1012

Implementation of the Independent Medicines and Medical Devices Safety Review recommendations

28 February 202219 Signatures

Primary sponsor

Cat Smith

Labour — Lancaster and Wyre

Motion Text

That this House notes that sodium valproate can cause serious problems in a developing baby; further notes that 10 per cent of babies whose mothers take sodium valproate during pregnancy are at risk of having a birth defect, and up to 40 per cent have problems with development and learning as they grow; welcomes the July 2020 Independent Medicines and Medical Devices Safety Review; and calls on the Government to implement its recommendations in full, including paying compensation to people disabled by sodium valproate.